GleamWall
中文EN

TELA TELA Bio, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1561921 · Fiscal year ends 12/31

Financial factors as of 2026-03-31 (2026Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.5%
TTM net income YoY8.3%
TTM EPS YoY41.5%
Revenue 3-yr CAGR21.5%
Net income 3-yr CAGR—

Margins

Gross margin67.3%
Operating margin-41.8%
Net margin-49.3%
FCF margin-37.4%
EBITDA margin-41.1%

Returns

ROE-616.6%
ROA-54.2%
ROIC (approx.)-192.9%
Asset turnover1.10x

Leverage & solvency

Liabilities / assets107.4%
Debt / equity—
Current ratio3.61x
Interest coverage-5.56x

Cash quality & payout

Operating cash flow / net income0.74x
Accruals ratio-13.8%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$80.28M$69.30M
Cost of revenue$25.55M$22.43M
Gross profit$54.34M$46.49M
R&D expense$9.22M$8.81M
SG&A expense$15.69M$14.72M
Operating income-$33.76M-$34.12M
Interest expense$5.25M$5.29M
Pretax income-$38.60M-$37.98M
Income tax$230,000-$144,000
Net income-$38.83M-$37.84M
EBITDA-$33.12M-$33.48M
EPS (basic)-0.83-1.33
EPS (diluted)-0.83-1.33
Weighted avg. shares (diluted)46.95M28.53M
Balance sheet
Cash & equivalents$50.84M$52.94M
Receivables$10.35M$10.10M
Inventory$11.02M$12.78M
Current assets$75.58M$78.07M
PP&E, net$2.23M$2.34M
Intangibles$1.36M$1.74M
Total assets$81.42M$86.57M
Current liabilities$17.98M$15.60M
Long-term debt$55.65M$41.12M
Total debt$55.65M$41.12M
Total liabilities$75.11M$58.11M
Shareholders' equity$6.31M$28.46M
Net debt$4.81M-$11.81M
Shares outstanding44.54M39.40M
Cash flow statement
Operating cash flow-$28.22M-$41.59M
Capital expenditure$448,000$989,000
Free cash flow-$28.67M-$42.58M
Investing cash flow$846,000$4.45M
Financing cash flow$25.75M$43.06M
Depreciation & amortization$630,000$632,000
Stock-based compensation$3.80M$4.36M

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.